Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

4,100.00p
   
  • Change Today:
    -90.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 3,800.00
  • Currency: UK Pounds
  • Shares Issued: 5.21m
  • Volume: 2,251
  • Market Cap: £213.58m

Bioventix appoints Bruce Hiscox as chief financial officer

By Iain Gilbert

Date: Wednesday 01 Jul 2020

LONDON (ShareCast) - (Sharecast News) - Antibodies developer Bioventix named Bruce Hiscock would join the group its new chief financial officer on Wednesday.
Hiscock, previously chief executive and CFO of everyLIFE Technologies, a technology business delivering digital care planning solutions to social care providers, will start in the role with immediate effect.

The AIM-listed group highlighted that Hiscock had held several CFO roles at both fast-growing listed and private companies over his 30-year career and was a member of the Institute of Chartered Accountants of Scotland.

As of 0940 BST, Bioventix shares were up 1.20% at 4,200p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 4,100.00p
Change Today -90.00p
% Change -2.15 %
52 Week High 4,500.00
52 Week Low 3,800.00
Volume 2,251
Shares Issued 5.21m
Market Cap £213.58m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.8% below the market average86.8% below the market average86.8% below the market average86.8% below the market average86.8% below the market average
80.77% below the sector average80.77% below the sector average80.77% below the sector average80.77% below the sector average80.77% below the sector average
Price Trend
52.93% below the market average52.93% below the market average52.93% below the market average52.93% below the market average52.93% below the market average
49.15% below the sector average49.15% below the sector average49.15% below the sector average49.15% below the sector average49.15% below the sector average
Income Not Available
Growth
77.45% above the market average77.45% above the market average77.45% above the market average77.45% above the market average77.45% above the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim Special
Ex-Div 08-Apr-21 29-Oct-20
Paid 23-Apr-21 13-Nov-20
Amount 43.00p 53.00p

Trades for 23-Jun-2021

Time Volume / Share Price
15:53 5 @ 4,100.00p
15:46 9 @ 4,065.00p
15:42 109 @ 4,050.00p
15:39 105 @ 4,050.00p
15:32 371 @ 4,050.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page